1993
DOI: 10.1016/0190-9622(93)70020-t
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous vasculitis in the newborn of a mother with cutaneous polyarteritis nodosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0
3

Year Published

2004
2004
2015
2015

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 9 publications
0
19
0
3
Order By: Relevance
“…[8][9][10] Rare cases of a transient vasculitidies seen in infants born to mothers with cutaneous polyarteritis nodosa have been described in which the vasculitis and LR pattern have been attributed to a maternal factor crossing the placenta. 11 Hematologic/hypercoaguable Antiphospholipid syndrome. The antiphospholipid syndrome is strictly defined as the presence of lupus anticoagulant antibodies or anticardiolipin antibodies and either vascular thrombosis or specific pregnancy complications.…”
Section: Lr With Systemic Associations (Secondary) Congenitalmentioning
confidence: 99%
“…[8][9][10] Rare cases of a transient vasculitidies seen in infants born to mothers with cutaneous polyarteritis nodosa have been described in which the vasculitis and LR pattern have been attributed to a maternal factor crossing the placenta. 11 Hematologic/hypercoaguable Antiphospholipid syndrome. The antiphospholipid syndrome is strictly defined as the presence of lupus anticoagulant antibodies or anticardiolipin antibodies and either vascular thrombosis or specific pregnancy complications.…”
Section: Lr With Systemic Associations (Secondary) Congenitalmentioning
confidence: 99%
“…CPAN is most common in school-aged children; however, cases occurring in some younger children have been reported. There have been 3 reports of similar clinical syndromes developing in newborns of mothers who had cutaneous vasculitis (Boren and Everett, 14 Miller and Fries, 15 and Stone et al 16 ). One of the mothers had had long-standing CPAN since 6 years of age; in the other 2 mothers symptoms developed during pregnancy.…”
Section: Discussionmentioning
confidence: 98%
“…Some patients respond well to nonsteroidal anti-inflammatory drugs alone; however, most require treatment with prednisone. [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] Additional medication may be needed to allow reduction in prednisone doses. In 1991, Jorizzo et al 18 reported that methotrexate treatment was effective in 3 patients with CPAN, including a child whose disease had not responded to prednisone (up to 60 mg/d), cyclophosphamide (100 mg/d), and colchicine (0.6 mg 3 times daily).…”
Section: Discussionmentioning
confidence: 99%
“…Считают, что пациентки с УП имеют высокий риск смертности, поэтому рекомен-дуется аборт [10]. Описано несколько случаев появ-ления УП в послеродовой период [17], а также не-сколько случаев (менее 10) кожного УП, спонтанно проявившегося у новорожденных, родившихся у ма-терей с кожным УП (как рецидив во время беремен-ности) [27,28].…”
Section: беременность у больных с системными первичными васкулитамиunclassified
“…Имеются два сообщения о бере-менности у больных с МПА [29,30], МПА развился на 16-й неделе беременности, и пациентка умерла от легочной инфекции [38], в другом случае МПА раз-вился на 24-й неделе беременности, ситуация разре-шилась благодаря плазмаферезу [30]. Риск рецидива МПА во время беременности менее 50% [20,[27][28][29][30]. Есть данные о случаях МПА после родов или после аборта [16, 19-21, 29, 31].…”
Section: беременность у больных с системными первичными васкулитамиunclassified